$UG
UNITED GUARDIAN INC

2021 Q4 Form 10-Q Financial Statement

#000117184321007870 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $3.661M $3.180M $2.336M
YoY Change 54.47% 36.1% -29.57%
Cost Of Revenue $1.567M $1.321M $974.8K
YoY Change 26.37% 35.47% -29.72%
Gross Profit $2.094M $1.859M $1.362M
YoY Change 85.31% 36.55% -29.47%
Gross Profit Margin 57.2% 58.47% 58.28%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $129.6K $130.7K $114.8K
YoY Change 7.99% 13.85% 9.58%
% of Gross Profit 6.19% 7.03% 8.43%
Depreciation & Amortization $39.05K $36.90K $40.00K
YoY Change -21.9% -7.75% -20.0%
% of Gross Profit 1.86% 1.98% 2.94%
Operating Expenses $736.8K $130.7K $114.8K
YoY Change 18.85% 13.85% 9.58%
Operating Profit $1.357M $1.270M $753.6K
YoY Change 166.11% 68.52% -41.19%
Interest Expense $46.27K $13.64K $150.0K
YoY Change -81.49% -90.91% 114.29%
% of Operating Profit 3.41% 1.07% 19.91%
Other Income/Expense, Net $13.64K $152.2K
YoY Change -91.04% 108.98%
Pretax Income $1.403M $1.284M $905.7K
YoY Change 84.66% 41.71% -33.12%
Income Tax $287.1K $267.0K $188.2K
% Of Pretax Income 20.46% 20.81% 20.78%
Net Earnings $1.116M $1.017M $717.5K
YoY Change 83.0% 41.67% -32.93%
Net Earnings / Revenue 30.49% 31.97% 30.71%
Basic Earnings Per Share $0.22
Diluted Earnings Per Share $243.0K $221.3K $156.9K
COMMON SHARES
Basic Shares Outstanding 4.594M 4.594M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.167M $9.585M $9.030M
YoY Change -0.16% 6.15% -5.35%
Cash & Equivalents $531.2K $691.9K $885.1K
Short-Term Investments $7.635M $8.893M $8.140M
Other Short-Term Assets $192.6K $159.4K $290.0K
YoY Change -25.93% -45.05% 7.41%
Inventory $1.411M $1.287M $1.545M
Prepaid Expenses
Receivables $1.813M $1.930M $1.284M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.58M $12.96M $12.15M
YoY Change 2.99% 6.7% -4.35%
LONG-TERM ASSETS
Property, Plant & Equipment $658.9K $663.5K $695.6K
YoY Change -2.2% -4.61% -14.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.706K
YoY Change -80.0%
Total Long-Term Assets $658.9K $663.5K $699.3K
YoY Change -2.2% -5.11% -16.01%
TOTAL ASSETS
Total Short-Term Assets $11.58M $12.96M $12.15M
Total Long-Term Assets $658.9K $663.5K $699.3K
Total Assets $12.24M $13.63M $12.85M
YoY Change 2.7% 6.06% -5.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $410.9K $87.16K $40.93K
YoY Change 1192.12% 112.97% -86.71%
Accrued Expenses $1.627M $1.543M $1.158M
YoY Change 19.36% 33.18% 7.16%
Deferred Revenue $190.2K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.338M $1.707M $1.218M
YoY Change 65.3% 40.19% -20.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.338M $1.707M $1.218M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.421M $1.934M $1.450M
YoY Change 54.2% 33.41% -17.61%
SHAREHOLDERS EQUITY
Retained Earnings $9.362M $11.23M $10.94M
YoY Change -5.39% 2.68% -3.29%
Common Stock $459.4K $459.4K $459.4K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.821M $11.69M $11.40M
YoY Change
Total Liabilities & Shareholders Equity $12.24M $13.63M $12.85M
YoY Change 2.7% 6.06% -5.07%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $1.116M $1.017M $717.5K
YoY Change 83.0% 41.67% -32.93%
Depreciation, Depletion And Amortization $39.05K $36.90K $40.00K
YoY Change -21.9% -7.75% -20.0%
Cash From Operating Activities $1.665M $1.031M -$260.0K
YoY Change 148.44% -496.7% -126.26%
INVESTING ACTIVITIES
Capital Expenditures -$34.38K -$43.24K -$30.00K
YoY Change 243.8% 44.13% -57.14%
Acquisitions
YoY Change
Other Investing Activities $1.195M -$1.041M -$1.040M
YoY Change 70.65% 0.07% 5100.0%
Cash From Investing Activities $1.160M -$1.084M -$1.060M
YoY Change 68.14% 2.26% 960.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.985M 0.000 0.000
YoY Change 80.93%
NET CHANGE
Cash From Operating Activities 1.665M 1.031M -260.0K
Cash From Investing Activities 1.160M -1.084M -1.060M
Cash From Financing Activities -2.985M 0.000 0.000
Net Change In Cash -160.7K -52.54K -1.320M
YoY Change -44.59% -96.02% -248.31%
FREE CASH FLOW
Cash From Operating Activities $1.665M $1.031M -$260.0K
Capital Expenditures -$34.38K -$43.24K -$30.00K
Free Cash Flow $1.699M $1.075M -$230.0K
YoY Change 149.84% -567.25% -121.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4594319
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27296 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14017 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3179746 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2336360 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10268592 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8613918 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1320509 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
974763 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4180912 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3634528 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
152180 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
164566 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
275150 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1283552 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
905737 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4474472 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3403292 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
267046 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
458582 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
493204 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1428721 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1520114 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130742 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114836 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
349053 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
331134 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
1909833 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
1582803 USD
us-gaap Costs And Expenses
CostsAndExpenses
5958686 USD
us-gaap Costs And Expenses
CostsAndExpenses
5485776 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1269913 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
753557 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4309906 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3128142 USD
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
38747 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
38932 USD
us-gaap Investment Income Net
InvestmentIncomeNet
124147 USD
us-gaap Investment Income Net
InvestmentIncomeNet
131318 USD
CY2021Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-25108 USD
CY2020Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
113248 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
40419 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
143832 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13639 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
188205 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
932240 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
708842 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1016506 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
717532 USD
us-gaap Net Income Loss
NetIncomeLoss
3542232 USD
us-gaap Net Income Loss
NetIncomeLoss
2694450 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.22
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.77
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.59
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
691921 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
591444 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8893454 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7591381 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1930183 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1387698 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
1287234 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1415773 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
159361 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
161208 USD
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
99107 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
12962153 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
11246611 USD
CY2021Q3 us-gaap Land
Land
69000 USD
CY2020Q4 us-gaap Land
Land
69000 USD
CY2021Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4571364 USD
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4516335 USD
CY2021Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2853718 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2848585 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7494082 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7433920 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6830549 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6760255 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
57614 USD
CY2021Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
19685 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
19028 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1707217 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1414285 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
227203 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
151684 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
663533 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
673665 USD
CY2021Q3 us-gaap Assets
Assets
13625686 USD
CY2020Q4 us-gaap Assets
Assets
11920276 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
87158 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31800 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1542760 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1363457 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
459432 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-128539 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
327542 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1847 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
40419 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
143832 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
14799 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13279 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-992 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
75519 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-155127 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
555764 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-815808 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3648744 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2921704 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81997 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25437 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1832829 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3802205 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3094483 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4932754 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
459432 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11231834 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9894875 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
11691266 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10354307 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13625686 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11920276 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10354307 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1181202 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11535509 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1344524 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
10674760 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1016506 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
11691266 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10632898 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
790307 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11423505 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1186611 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
10680202 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
717532 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
11397734 USD
us-gaap Net Income Loss
NetIncomeLoss
3542232 USD
us-gaap Net Income Loss
NetIncomeLoss
2694450 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
106928 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121669 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4185 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-99107 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-38969 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
55358 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-30460 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
179303 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
29233 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
57614 USD
ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
-124657 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1343651 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1155986 USD
CY2020Q4 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
302713 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2204616 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1928969 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2204616 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1928969 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100477 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-163251 USD
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
128636 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1048311 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591444 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
691921 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
885060 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
700000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
825000 USD
us-gaap Dividends
Dividends
657 USD
us-gaap Dividends
Dividends
645 USD
ug Tradein Received From Sale Of Asset
TradeinReceivedFromSaleOfAsset
29000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 27pt;text-indent:-27pt;"><em style="font: inherit;">2.</em>       Basis of Presentation</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 27pt;">Interim condensed financial statements of the Company are prepared in accordance with United States Generally Accepted Accounting Principles (“US GAAP”) for interim financial information, pursuant to the requirements for reporting on Form <em style="font: inherit;">10</em>-Q and Regulation S-<em style="font: inherit;">X.</em> In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for the fair presentation of financial statements for the interim periods have been included. The results of operations for the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2021 (</em>also referred to as the "third quarter of <em style="font: inherit;">2021"</em> and the "first <em style="font: inherit;">nine</em> months of <em style="font: inherit;">2021",</em> respectively) are <em style="font: inherit;">not</em> necessarily indicative of results that ultimately <em style="font: inherit;"> may </em>be achieved for any other interim period or for the year ending <em style="font: inherit;"> December 31, 2021. </em>The interim unaudited condensed financial statements and notes thereto should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2020.</em></p>
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
653000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
27296 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14017 USD
CY2021Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
806000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3179746 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2336360 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10268592 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8613918 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3179746 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2336360 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10268592 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8613918 USD
CY2021Q3 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-25108 USD
CY2020Q3 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
113248 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
40419 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
143832 USD
CY2020Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
25062 USD
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
112180 USD
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
29918 USD
CY2020Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
88186 USD
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-71761 USD
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
113914 USD
CY2021Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-25108 USD
CY2021Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
8660985 USD
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
8893454 USD
CY2021Q3 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
232469 USD
CY2021Q3 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
8660985 USD
CY2021Q3 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
8893454 USD
CY2021Q3 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
232469 USD
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
7287151 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
7591381 USD
CY2020Q4 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
304230 USD
CY2020Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7287151 USD
CY2020Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
7591381 USD
CY2020Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
304230 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1832829 USD
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
112180 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3802205 USD
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
29918 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
434178 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
415415 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
75716 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
59258 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
777340 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
941100 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
1287234 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100 USD
CY2021Q3 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
311311 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
150 USD
CY2021Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-73935 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1415773 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000 USD
CY2020Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
106882 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
856621 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
863819 USD
CY2021Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
340981 USD
CY2020Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
81323 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
75519 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-155127 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
267046 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
188205 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
932240 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
708842 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
87000 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
108750 USD
CY2021Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
237000 USD
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
210000 USD
CY2021Q3 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
362315 USD
CY2020Q4 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
325792 USD
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
225328 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
245521 USD
CY2021Q3 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
311311 USD
CY2020Q4 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
302713 USD
CY2021Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
87000 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
128636 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
57875 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
50500 USD
CY2021Q3 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
46462 USD
CY2020Q4 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
63432 USD
CY2021Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
51428 USD
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
149346 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35405 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16153 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1542760 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1363457 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.77
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.59
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.22
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.16

Files In Submission

Name View Source Status
0001171843-21-007870-index-headers.html Edgar Link pending
0001171843-21-007870-index.html Edgar Link pending
0001171843-21-007870.txt Edgar Link pending
0001171843-21-007870-xbrl.zip Edgar Link pending
ex_303096.htm Edgar Link pending
ex_303097.htm Edgar Link pending
ex_303098.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ug-20210930.xsd Edgar Link pending
ug-20210930_cal.xml Edgar Link unprocessable
ug-20210930_def.xml Edgar Link unprocessable
ug-20210930_lab.xml Edgar Link unprocessable
ug-20210930_pre.xml Edgar Link unprocessable
ug20210930_10q.htm Edgar Link pending
ug20210930_10q_htm.xml Edgar Link completed